<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335481">
  <stage>Registered</stage>
  <submitdate>13/05/2010</submitdate>
  <approvaldate>26/05/2010</approvaldate>
  <actrnumber>ACTRN12610000421033</actrnumber>
  <trial_identification>
    <studytitle>Autologous Umbilical Cord Blood Mononuclear Layer Transfusion for Neonates with Encephalopathy:  A Pilot Feasibility Study</studytitle>
    <scientifictitle>Efficacy of Autologous Umbilical Cord Blood Mononuclear Layer Transfusion to Prevent Brain injury after Neonatal encephalopathy.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Neonatal Encephalopathy.</healthcondition>
    <healthcondition>Asphyxia and traumatic brain injury.</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Complications of newborn</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Autologous cord blood collection after birth of the baby (10 min), immediately followed by Mononuclear cell layer (MNCL) separation by density gradient centrifugation (30 min), immediately followed by MNCL transfusion over 30 minutes to preterm or full term neonate with signs of encephalopathy.</interventions>
    <comparator>Historical data will be collected from files for neonates with encephalopathy admitted to the Neonatal Intensive Care Unit (NICU) during the period from 2005 till 2010. They were treated with supportive care.</comparator>
    <control>Historical</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Adverse event rates occurring in the pilot study population will be compared between the cord blood cell recipients and historical controls. Occurance of blood pressure fluctuation, changes in heart rate, reaction to blood transfusion. The baby will be monitored for mean arterial blood pressure and heart rate and blood analysis .</outcome>
      <timepoint>1 month following transfusion.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Prevention of brain injury as measured by neurodevelopmental function at 4 - 6 months and 9 - 12 months of age.Bayley II Scales of Infant Development will be used.</outcome>
      <timepoint>4-6 months and 9-12 months of age.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Magnetic resonance imaging (MRI) findings compared to historical non interventional group. MRI score will be used.</outcome>
      <timepoint>1 year of age.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>*Mothers must have consented for cord blood collection at delivery
*cord blood must be available for extraction of stem cells.
*&gt;30 weeks gestation
*High risk pregnancies.
*All infants must have signs of encephalopathy within 6 hours of age.</inclusivecriteria>
    <inclusiveminage>1</inclusiveminage>
    <inclusiveminagetype>Hours</inclusiveminagetype>
    <inclusivemaxage>24</inclusivemaxage>
    <inclusivemaxagetype>Hours</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>*Presence of known chromosomal anomaly.
*Presence of major congenital anomalies.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/06/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Cairo</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Ain Shams University, Faculty of Medicine</primarysponsorname>
    <primarysponsoraddress>Abassia square/Cairo. 11588</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Pediatric department , Children's Hospital</sponsorname>
      <sponsoraddress>Faculty of Medicine/Ain Shams University/Abassia square/Cairo. 11588</sponsoraddress>
      <sponsorcountry>Egypt</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Maternity Hospital/ Ain Shams University</othercollaboratorname>
      <othercollaboratoraddress>Faculty of Medicine/Ain Shams University/Abassia square/Cairo. 11588</othercollaboratoraddress>
      <othercollaboratorcountry>Egypt</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Neonatal Intensive Care Unit-Maternity Hospital/ Ain Shams University</othercollaboratorname>
      <othercollaboratoraddress>Faculty of Medicine/Ain Shams University/Abassia square/Cairo.11588</othercollaboratoraddress>
      <othercollaboratorcountry>Egypt</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary objective of this study is to determine feasibility and safety of the procedure of cord blood collection, preservation and autologus transfusion. The protective effect of mononuclear layer transfusion for neonates with encephalopathy, to decrease long term sequel.</summary>
    <trialwebsite />
    <publication>1.	Robertson, C.M., N.N. Finer, and M.G. Grace, School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr, 1989. 114(5): p. 753-60.
2.	CDC, Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003. MMWR Morb Mortal Wkly Rep, 2004. 53(3): p. 57-9.
3.	Campbell, O., et al., The Egypt National Perinatal/Neonatal Mortality Study 2000. J Perinatol, 2004. 24(5): p. 284-9.
4.	Sanberg, P.R., et al., Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci, 2005. 1049: p. 67-83.
5.	Buschmann, I.R., et al., GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis, 2001. 159(2): p. 343-56.
6.	Taguchi, A., et al., Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest, 2004. 114(3): p. 330-8.
7.	Peterson, D.A., Umbilical cord blood cells and brain stroke injury: bringing in fresh blood to address an old problem. J Clin Invest, 2004. 114(3): p. 312-4.
8.	Sanchez-Ramos, J.R., et al., Expression of neural markers in human umbilical cord blood. Exp Neurol, 2001. 171(1): p. 109-15.
9.	Bicknese, A.R., et al., Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant, 2002. 11(3): p. 261-4.
10.	Fraidenraich, D., et al., Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells. Science, 2004. 306(5694): p. 247-52.
11.	Buzanska, L., M. Jurga, and K. Domanska-Janik, Neuronal differentiation of human umbilical cord blood neural stem-like cell line. Neurodegener Dis, 2006. 3(1-2): p. 19-26.
12.	Shellhaas, R.A., P.R. Gallagher, and R.R. Clancy, Assessment of neonatal electroencephalography (EEG) background by conventional and two amplitude-integrated EEG classification systems. J Pediatr, 2008. 153(3): p. 369-74.
13.	Luan, Z., et al., [Treatment of an infant with severe neonatal hypoxic-ischemic encephalopathy sequelae with transplantation of human neural stem cells into cerebral ventricle]. Zhonghua Er Ke Za Zhi, 2005. 43(8): p. 580-3; discussion 580.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ain Shams Medical School. Surgery Department</ethicname>
      <ethicaddress>Faculty of Medicine/Ain Shams University/Abassia square/Cairo.11588</ethicaddress>
      <ethicapprovaldate>1/03/2010</ethicapprovaldate>
      <hrec>IRB 00006379</hrec>
      <ethicsubmitdate>2/02/2010</ethicsubmitdate>
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof. Dr. Sahar MA Hassanein</name>
      <address>Faculty of Medicine/Ain Shams University/Abassia square/Cairo. 11588</address>
      <phone>+20123183943</phone>
      <fax />
      <email>saharhassanein@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof. Dr. Sahar MA Hassanein</name>
      <address>129 Merghani St., Heliopolies. Cairo. Egypt. 11361</address>
      <phone>+20123183943</phone>
      <fax />
      <email>saharhassanein@yahoo.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof. Dr. Sahar MA Hassanein</name>
      <address>Department of Pediatrics. Faculty of Medicine/Ain Shams University/Abassia square/Cairo. 11588</address>
      <phone />
      <fax />
      <email>saharhassanein@yahoo.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>